Hamlin Capital Management, LLC, a registered investment adviser, initiated a new position in CVS Health Corporation (NYSE:CVS) during Q4 2025, according to its most recent 13F…
Hamlin Capital Management, LLC, a registered investment adviser, initiated a new position in CVS Health Corporation (NYSE:CVS) during Q4 2025, according to its most recent 13F filing with the Securities and Exchange Commission.
The institutional investor purchased 2,026,761 shares of the Healthcare company, valued at approximately $160,843,753 as of the filing date.
CVS Health Corporation's stock currently trades at $80.35 with a market capitalization of $102,620,922,087.
Current market data
NYSE · CVS
$85.86
Down: -$0.67 · -0.78%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
analyst ·
institutional ·
institutional ·
analyst ·
